These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37338617)

  • 1. Association of Antibody Responses to Fusobacterium nucleatum and Streptococcus gallolyticus Proteins with Colorectal Adenoma and Colorectal Cancer.
    Genua F; Butt J; Waterboer T; Hughes DJ
    Dig Dis Sci; 2023 Aug; 68(8):3300-3311. PubMed ID: 37338617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serology of Streptococcus gallolyticus subspecies gallolyticus and its association with colorectal cancer and precursors.
    Butt J; Werner S; Willhauck-Fleckenstein M; Michel A; Waterboer T; Zörnig I; Boleij A; Dramsi S; Brenner H; Pawlita M
    Int J Cancer; 2017 Sep; 141(5):897-904. PubMed ID: 28477334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of
    Périchon B; Lichtl-Häfele J; Bergsten E; Delage V; Trieu-Cuot P; Sansonetti P; Sobhani I; Dramsi S
    Front Cell Infect Microbiol; 2022; 12():794391. PubMed ID: 35360109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer.
    Butt J; Jenab M; Willhauck-Fleckenstein M; Michel A; Pawlita M; Kyrø C; Tjønneland A; Boutron-Ruault MC; Carbonnel F; Severi G; Kaaks R; Kühn T; Boeing H; Trichopoulou A; la Vecchia C; Karakatsani A; Panico S; Tumino R; Agnoli C; Palli D; Sacerdote C; Bueno-de-Mesquita HBA; Weiderpass E; Sánchez MJ; Bonet Bonet C; Huerta JM; Ardanaz E; Bradbury K; Gunter M; Murphy N; Freisling H; Riboli E; Tsilidis K; Aune D; Waterboer T; Hughes DJ
    Int J Cancer; 2018 Jul; 143(2):245-252. PubMed ID: 29377173
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hussan H; Clinton SK; Roberts K; Bailey MT
    World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
    Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Streptococcus gallolyticus subspecies gallolyticus with colorectal cancer: Serological evidence.
    Butt J; Romero-Hernández B; Pérez-Gómez B; Willhauck-Fleckenstein M; Holzinger D; Martin V; Moreno V; Linares C; Dierssen-Sotos T; Barricarte A; Tardón A; Altzibar JM; Moreno-Osset E; Franco F; Requena RO; Huerta JM; Michel A; Waterboer T; Castaño-Vinyals G; Kogevinas M; Pollán M; Boleij A; de Sanjosé S; Del Campo R; Tjalsma H; Aragonés N; Pawlita M
    Int J Cancer; 2016 Apr; 138(7):1670-9. PubMed ID: 26537841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody Responses to
    Butt J; Blot WJ; Teras LR; Visvanathan K; Le Marchand L; Haiman CA; Chen Y; Bao Y; Sesso HD; Wassertheil-Smoller S; Ho GY; Tinker LF; Peek RM; Potter JD; Cover TL; Hendrix LH; Huang LC; Waterboer T; Pawlita M; Epplein M
    Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1186-1194. PubMed ID: 30038049
    [No Abstract]   [Full Text] [Related]  

  • 10. Intestinal microbiota and its association with colon cancer and red/processed meat consumption.
    Abu-Ghazaleh N; Chua WJ; Gopalan V
    J Gastroenterol Hepatol; 2021 Jan; 36(1):75-88. PubMed ID: 32198788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
    Bundgaard-Nielsen C; Baandrup UT; Nielsen LP; Sørensen S
    BMC Cancer; 2019 Apr; 19(1):399. PubMed ID: 31035942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
    Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
    Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
    Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody Responses to
    Butt J; Jenab M; Pawlita M; Overvad K; Tjonneland A; Olsen A; Boutron-Ruault MC; Carbonnel F; Mancini FR; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Palli D; Pala VM; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita B; van Gils CH; Vermeulen RCH; Weiderpass E; Quirós JR; Duell EJ; Sánchez MJ; Dorronsoro M; Huerta JM; Ardanaz E; Van Guelpen B; Harlid S; Perez-Cornago A; Gunter MJ; Murphy N; Freisling H; Aune D; Waterboer T; Hughes DJ
    Cancer Epidemiol Biomarkers Prev; 2019 Sep; 28(9):1552-1555. PubMed ID: 31481495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
    Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
    mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.